Fluxion Biosciences, a privately held drug discovery tools company, announced today that it has added 4 new senior management positions and expanded sales and technical support globally. The new ...

Fluxion Biosciences, Inc. announced today that the University of Michigan Department of Chemistry has purchased the IonFlux 16 automated patch clamp instrument. The IonFlux system will enable detailed ...

Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput ...

Fluxion Biosciences, Inc. announced a new capability to include full-service clinical sample procurement that will expand Fluxion’s IsoFlux Discovery Services offering. Fluxion currently offers a ...

Fluxion Biosciences has announced that it has signed a distribution agreement for EMD Millipore’s PrecisION® range of ion channel cell lines. The non-exclusive distribution agreement will combine ...

The Spotlight 59™ panel and novel ERASE-Seq methodology are designed for ultra-sensitive variant detection from CTCs and cfDNA SAN FRANCISCO, Oct. 27, 2016 /PRNewswire/ -- Fluxion Biosciences, Inc.

ALAMEDA, Calif., Dec. 13, 2019 /PRNewswire/ -- Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53. These new ...

Fluxion Biosciences Launches New Range of Circulating Tumor Cell (CTC) Recovery Kits- First Launch of Commercial Kits Targeting EMT Cells New kits add additional markers to improve capture efficiency ...